| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2873955 | The Annals of Thoracic Surgery | 2013 | 8 Pages |
Abstract
In these early results, TEVAR reduces operative morbidity and mortality compared with open aortic replacement in the treatment of CD3 aneurysms. The TEVAR is effective in remodeling the chronically dissected thoracic aorta. Abdominal false lumen patency is maintained in patients with thoracoabdominal dissection-related aneurysms.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Bradley G. MD, Wilson Y. MD, Alberto MD, Nimesh D. MD, PhD, Patrick J. MS, Derek P. MD, Benjamin M. MD, Edward Y. MD, Ronald M. MD, Joseph E. MD,